Indivior Seeks DEA Registration to Import Thebaine for Research
March 06, 2025
March 06, 2025
WASHINGTON, March 6 (TNSFR) -- Indivior Inc. has applied to the Drug Enforcement Administration (DEA) for registration as an importer of the Schedule II controlled substance thebaine.
The company, based in Fort Collins, Colorado, intends to import the substance in limited quantities strictly for research, clinical trials, analytical purposes, and the development of a manufacturing process for dosage forms. The DEA will evaluate the application to ensure compliance with federal regu . . .
The company, based in Fort Collins, Colorado, intends to import the substance in limited quantities strictly for research, clinical trials, analytical purposes, and the development of a manufacturing process for dosage forms. The DEA will evaluate the application to ensure compliance with federal regu . . .